about
Establishment, characterization and chemosensitivity of three mismatch repair deficient cell lines from sporadic and inherited colorectal carcinomasMultidrug-resistance proteins are weak tumor associated antigens for colorectal carcinoma.Cryopreservation of human colorectal carcinomas prior to xenografting.Semiallogenic fusions of MSI(+) tumor cells and activated B cells induce MSI-specific T cell responsesAn MSI tumor specific frameshift mutation in a coding microsatellite of MSH3 encodes for HLA-A0201-restricted CD8+ cytotoxic T cell epitopesBacterial immunotherapy of gastrointestinal tumors.Tumor-infiltrating B cells come into vogueTumor Take Rate Optimization for Colorectal Carcinoma Patient-Derived Xenograft ModelsMicrodensitometry of osteopontin as an immunohistochemical prognostic biomarker in colorectal carcinoma tissue microarrays: potential and limitations of the method in 'biomarker pathology'.Avitalized bacteria mediate tumor growth control via activation of innate immunity.Tumor-infiltrating B cells: The ignored players in tumor immunology.Deciphering molecular mechanisms of arginine deiminase-based therapy - Comparative response analysis in paired human primary and recurrent glioblastomas.Lysates of S. pyogenes serotype M49 induce pancreatic tumor growth delay by specific and unspecific antitumor immune responses.Impact of portal branch ligation on tissue regeneration, microcirculatory response and microarchitecture in portal blood-deprived and undeprived liver tissue.Targeting Immune-Related Molecules in Cancer Therapy: A Comprehensive Analysis on Patient-Derived Tumor ModelsRecombinant gp100 protein presented by dendritic cells elicits a T-helper-cell response in vitro and in vivoIntranasal immunization with human papillomavirus type 16 capsomeres in the presence of non-toxic cholera toxin-based adjuvants elicits increased vaginal immunoglobulin levelsThe EpCAM high/CD44 high colorectal carcinoma stem cell phenotype is not preferentially expressed in tumour budsStreptamer-based selection of WT1-specific CD8+ T cells for specific donor lymphocyte infusionsIntegrated Biobanking and Tumor Model Establishment of Human Colorectal Carcinoma Provides Excellent Tools for Preclinical ResearchA Subset of Colorectal Cancers with Cross-Sensitivity to Olaparib and OxaliplatinConnecting Cancer Pathways to Tumor Engines: A Stratification Tool for Colorectal Cancer Combining Human In Vitro Tissue Models with Boolean In Silico ModelsPatient-Derived Xenografts and Matched Cell Lines Identify Pharmacogenomic Vulnerabilities in Colorectal Cancer
P50
Q28484668-78E6ED60-35B2-43F9-A0FB-496496424630Q31022597-04B8F4A2-957D-4238-88EA-C9ECD951A3DCQ33628095-F56263BD-4BDB-48B1-BE7D-6D2933CB0FFAQ34028964-EAF2CEAC-86CA-436F-A731-F154F4231C06Q34081414-DDF2DD34-0F27-4B9D-A7F7-6E2DFDA97032Q34242204-2A012B23-BAC1-4B3F-A3AB-94B61EFE1427Q36525540-48AC3893-0DB3-4549-8C4D-EA527496BB8FQ37479229-998E97E4-966C-4E79-BFC8-2C6E3140900AQ39258136-CE1F549F-7D8D-4735-BD23-963A48C96EE5Q39564765-43442649-5E3D-4C21-9A23-250C45E153FCQ41275029-6C8CA975-72E2-4B98-997E-A715A07E694AQ41921870-8462F436-3D50-49D2-936A-3E78EFF8995DQ46380342-57FF883A-0651-4EDA-92A8-1DA05FD14315Q50542814-D7053659-9752-4957-8ABB-F922D743C57EQ64229427-F3DE67F7-B33C-40FA-82CD-4AA4E8E48E1BQ73046709-928F5C46-CB2F-4917-9C98-BDF5E530055CQ82456786-721C39A3-BB52-4C3A-A804-E6D73BD8AF2AQ84202566-12973285-10E1-4221-9C7E-C7A36924E639Q84574957-4579A862-98FC-46F2-9CC4-643341E7E341Q90633582-3F8B97E3-D898-421F-B382-F139AD50118EQ91930559-A0221EA4-6F53-482A-A95D-D52946661077Q92156686-F70605D2-D893-42A2-9D37-C5F2EF04603BQ92376032-107E6A15-F964-446E-AF4D-2F8A0119BFF9
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Michael Linnebacher
@ast
Michael Linnebacher
@en
Michael Linnebacher
@es
Michael Linnebacher
@nl
Michael Linnebacher
@sl
type
label
Michael Linnebacher
@ast
Michael Linnebacher
@en
Michael Linnebacher
@es
Michael Linnebacher
@nl
Michael Linnebacher
@sl
prefLabel
Michael Linnebacher
@ast
Michael Linnebacher
@en
Michael Linnebacher
@es
Michael Linnebacher
@nl
Michael Linnebacher
@sl
P214
P106
P21
P214
P31
P496
0000-0001-8054-1402
P735
P7859
viaf-281739478